Better Therapeutics, Inc. (BTTX)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2022 | -860 Thousand USD | 97.23% |
| 2021 | -31.06 Million USD | -6107.93% |
| 2020 | 517 Thousand USD | -87.82% |
| 2019 | 4.24 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 Q1 | 8.47 Million USD | 1085.12% |
| 2023 Q2 | 8.01 Million USD | -5.38% |
| 2023 Q3 | 7.7 Million USD | -3.83% |
| 2022 Q3 | -7.51 Million USD | 49.85% |
| 2022 Q2 | -14.99 Million USD | 32.06% |
| 2022 Q1 | -22.07 Million USD | 28.95% |
| 2022 FY | -860 Thousand USD | 97.23% |
| 2022 Q4 | -860 Thousand USD | 88.56% |
| 2021 FY | -31.06 Million USD | -6107.93% |
| 2021 Q4 | -31.06 Million USD | -12401.41% |
| 2021 Q3 | -248.46 Thousand USD | 88.27% |
| 2021 Q2 | -2.11 Million USD | -439.06% |
| 2021 Q1 | -392.9 Thousand USD | -319333.33% |
| 2020 Q4 | -123.00 USD | 0.0% |
| 2020 FY | 517 Thousand USD | -87.82% |
| 2020 Q1 | 757.00 USD | 0.0% |
| 2019 FY | 4.24 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| America Great Health | 1.81 Million USD | 147.354% |
| Ampio Pharmaceuticals, Inc. | -3.81 Million USD | 77.457% |
| Aridis Pharmaceuticals, Inc. | 1.25 Million USD | 168.581% |
| Biora Therapeutics, Inc. | 32.21 Million USD | 102.67% |
| Bio-Path Holdings, Inc. | -939 Thousand USD | 8.413% |
| Calithera Biosciences, Inc. | -23.78 Million USD | 96.384% |
| Comera Life Sciences Holdings, Inc. | 328.44 Thousand USD | 361.843% |
| Gene Biotherapeutics, Inc. | - USD | Infinity% |
| eFFECTOR Therapeutics, Inc. | 4.57 Million USD | 118.818% |
| Eloxx Pharmaceuticals, Inc. | -5.82 Million USD | 85.231% |
| Evelo Biosciences, Inc. | 3.19 Million USD | 126.892% |
| Evolutionary Genomics, Inc. | 3.16 Million USD | 127.158% |
| Finch Therapeutics Group, Inc. | 5 Million USD | 117.193% |
| Galera Therapeutics, Inc. | 134.04 Million USD | 100.642% |
| Innovation1 Biotech Inc. | 179.15 Thousand USD | 580.045% |
| Kiromic BioPharma, Inc. | 12.33 Million USD | 106.97% |
| Molecular Templates, Inc. | 707 Thousand USD | 221.641% |
| Navidea Biopharmaceuticals, Inc. | 438.44 Thousand USD | 296.148% |
| NexImmune, Inc. | -3.13 Million USD | 72.556% |
| Orgenesis Inc. | 21.78 Million USD | 103.948% |
| Panbela Therapeutics, Inc. | 2.61 Million USD | 132.875% |
| Point of Care Nano-Technology, Inc. | -498.00 USD | -172590.763% |
| PaxMedica, Inc. Common Stock | -4.71 Million USD | 81.743% |
| Scopus BioPharma Inc. | -124.57 Thousand USD | -590.347% |
| Sorrento Therapeutics, Inc. | 110.87 Million USD | 100.776% |
| Statera Biopharma, Inc. | 14.41 Million USD | 105.965% |
| TRACON Pharmaceuticals, Inc. | -7.59 Million USD | 88.678% |
| Trevena, Inc. | 2.25 Million USD | 138.087% |
| Vaxxinity, Inc. | 10.13 Million USD | 108.488% |
| Vaccinex, Inc. | -1.28 Million USD | 33.23% |
| Vicapsys Life Sciences, Inc. | 344.44 Thousand USD | 349.676% |
| Viracta Therapeutics, Inc. | 13.23 Million USD | 106.496% |
| ZIVO Bioscience, Inc. | 71.96 Thousand USD | 1295.075% |